LOGO
LOGO

Article Search

Discover the power of RTTNews website's advanced search page, designed for seamless Article retrieval by Company Name, Stock Symbol, and other criteria.
Stay updated with the Latest News on specific Companies, Financial Insights, and Market Trends. We Ensure you to get the most relevant information instantly.

Symbol  
Company  
Currency Symbol   eg (EUR/USD)
Keyword  
  • Wedbush Is Raising Cartesian Therapeutics, Inc. (RNAC) Q4 27 Estimate To -0.49 From -0.68 3/9/2026 11:40:36 AM
  • Wedbush Is Increasing Cartesian Therapeutics, Inc. (RNAC) Q3 27 Estimate To -0.47 From -0.66 3/9/2026 11:40:25 AM
  • Wedbush Is Raising Cartesian Therapeutics, Inc. (RNAC) Q2 27 Estimate To -0.48 From -0.66 3/9/2026 11:39:59 AM
  • Wedbush Is Increasing Cartesian Therapeutics, Inc. (RNAC) Q1 27 Estimate To -0.52 From -0.72 3/9/2026 11:39:46 AM
  • Wedbush Is Increasing Cartesian Therapeutics, Inc. (RNAC) FY 26 Estimate To -2.51 From -2.96 3/9/2026 11:39:32 AM
  • Wedbush Is Raising Cartesian Therapeutics, Inc. (RNAC) Q4 26 Estimate To -0.52 From -0.71 3/9/2026 11:39:20 AM
  • Wedbush Is Raising Cartesian Therapeutics, Inc. (RNAC) Q3 26 Estimate To -0.52 From -0.69 3/9/2026 11:39:08 AM
  • Wedbush Is Lowering Cartesian Therapeutics, Inc. (RNAC) Q2 26 Estimate To -0.79 From -0.69 3/9/2026 11:38:56 AM
  • Wedbush Is Raising Cartesian Therapeutics, Inc. (RNAC) Q1 26 Estimate To -0.82 From -0.93 3/9/2026 11:38:41 AM
  • Wedbush Reiterates Cartesian Therapeutics, Inc. (RNAC) At Outperform With $38 Price Target 3/9/2026 11:38:12 AM
  • Cartesian Therapeutics FY25 Loss/shr $5.02 Vs Loss/shr $4.49 Last Year 3/9/2026 7:23:43 AM
  • Cartesian Therapeutics Announces 2026 Strategic Priorities Advancing Cell Therapy Pipeline For Autoimmune Diseases 1/9/2026 8:15:47 AM
  • Cartesian Therapeutics Appoints Adrian Bot To Board Of Directors 12/18/2025 4:19:26 PM
  • Wedbush Is Cutting Cartesian Therapeutics, Inc. (RNAC) FY 26 Estimate To -2.96 From -2.83 11/14/2025 11:34:46 PM
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap